Innoviva (INVA) Misses Q4 EPS by 6c

Innoviva (NASDAQ: INVA) reported Q4 EPS of $0.26, $0.06 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $91.81 million versus the consensus estimate of $84.3 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• Envista Holdings (NVST) Reiterated at Buy by Stifel on Raised Mid-Term Objectives
• Philip Morris (PM) Reiterated at Buy by Stifel - 'Bullish on Growth Prospects'
• W. P. Carey (WPC) Declares $0.950 Quarterly Dividend; 5.7% Yield